Nakamura K, Toyohira H, Kariyazono H, Yamada K, Moriyama Y, Taira A
Department of Hospital Pharmacy, Kagoshima University Faculty of Medicine, Japan.
Thromb Res. 1997 Apr 15;86(2):161-71. doi: 10.1016/s0049-3848(97)00059-5.
Prothrombin fragment 1 + 2 (F1 + 2), thrombin-antithrombin III complex (TAT), D-dimer and other coagulation-related factors were measured over time in 48 patients who underwent prosthetic valve replacement and subsequent anticoagulant therapy, in order to evaluate the dynamics of thrombin generation. Before surgery, levels of both F1 + 2 and TAT were high, indicating enhanced thrombin generation. On the 7th day after initiation of postoperative administration of warfarin, F1 + 2 was significantly lower than preoperatively, while TAT tended to be increased. Even on the 21st day, levels of both F1 + 2 and TAT were still high. Despite the administration of warfarin, thrombin generation increased in these patients. After surgery, D-dimer level was increased, indicating hyperfibrinolysis. On the 21st day after initiation of warfarin administration, abnormally high levels of F1 + 2 were observed in 4 of the 48 patients. In these 4 patients, thrombin generation was markedly increased, suggesting that they were in a preliminary stage of thrombogenesis. Antiplatelet therapy did not affect the levels of F1 + 2 or TAT. Our findings suggest that both F1 + 2 and TAT levels are useful for evaluation of enhanced coagulability. D-dimer is also considered to be useful as a parameter of fibrinolysis. F1 + 2 is less affected by surgical invasion than TAT, and therefore appeared to reflect coagulability more accurately.
对48例行人工瓣膜置换术及后续抗凝治疗的患者,随时间测定凝血酶原片段1+2(F1+2)、凝血酶-抗凝血酶III复合物(TAT)、D-二聚体及其他凝血相关因子,以评估凝血酶生成的动态变化。术前,F1+2和TAT水平均较高,表明凝血酶生成增强。术后开始使用华法林第7天,F1+2显著低于术前,而TAT有升高趋势。即使在第21天,F1+2和TAT水平仍较高。尽管使用了华法林,这些患者的凝血酶生成仍增加。术后,D-二聚体水平升高,表明存在纤维蛋白溶解亢进。在开始使用华法林第21天,48例患者中有4例F1+2水平异常升高。在这4例患者中,凝血酶生成明显增加,提示他们处于血栓形成的初始阶段。抗血小板治疗未影响F1+2或TAT水平。我们的研究结果表明,F1+2和TAT水平均有助于评估凝血性增强。D-二聚体也被认为是纤维蛋白溶解的有用参数。F1+2受手术侵袭的影响比TAT小,因此似乎更准确地反映了凝血性。